Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK2 receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 2, 1999, Pages 487-495

  Renzetti, Anna Rita ^a,c   Catalioto, R M ^a   Criscuoli, M ^a   Cucchi, P ^a   Ferrer, C ^a   Giolitti, A ^a   Guelfi, M ^a   Rotondaro, L ^a   Warner, F J ^b   Maggi, C A ^a  

^a Menarini Ricerche SpA   (Italy)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Pharmacology Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEPADUTANT; NEUROKININ A; SAREDUTANT; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST;

ARTICLE; BINDING COMPETITION; CHEMICAL STRUCTURE; CHO CELL; HUMAN; HUMAN CELL; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALS; BENZAMIDES; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; DNA, COMPLEMENTARY; HUMANS; INDOLES; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEUROKININ A; PEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; PROTEIN CONFORMATION; RECEPTORS, NEUROKININ-2;

EID: 0032789118     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 2 receptors. Eur J Pharmacol 272:241-248.
2. Bhogal N, Donnelly D and Findlay JBC (1994) The ligand binding site of the neurokinin 2 receptor. J Biol Chem 269:27269-27274.
3. 2 receptor antagonist. Br J Pharmacol 123:81-91.
4. 2 receptor. Pharmacology 41:184-194.
5. 2) receptor. Life Sci Pharmacol Lett 50: PL101-106.
6. 1 receptor and CP 96,345. Nature (Lond) 362:350-353.
7. Fong TM, Huang R-RC and Strader CD (1992) Localization of agonist and antagonist binding domains of the human NK-1 receptor. J Biol Chem 267:25664-25667.
8. 1 (substance P) receptor. Mol Pharmacol 45:500-508.
9. 1 receptor for substance P and a nonpeptide antagonist. Nature (Lond) 362:345-348.
10. 2 receptors. Proc Natl Acad Sci USA 90:6194-6198.
11. 1 receptor. Mol Pharmacol 53:166-175.
12. Huang R-RC, Vicario PP, Strader CD and Fong TM (1995) Identification of residues involved in ligand binding to the neurokinin 2 receptor. Biochemistry 34:10048-10055.
13. Huang R-RC, Yu H, Strader CD and Fong TM (1994) Interaction of substance P with the II and VII transmembrane domains of the NK-1 receptor. Biochemistry 33:3007-3013.
14. Maggi CA (1995) The mammalian tachykinin receptors. Gen Pharmacol 26:911-944.
15. Maggi CA, Giuliani S, Ballati L, Lecci A, Manzini S, Patacchini R, Renzetti AR, Rovero P, Quartara L and Giachetti A (1991) In vivo evidence for tachykininergic transmission using a new NK-2 receptor selective antagonist, MEN 10376. J Pharmacol Exp Ther 257:1172-1178.
16. Maggi CA, Patacchini R, Rovero P and Giachetti A (1993) Tachykinin receptors and receptor antagonists. J Auton Pharmacol 13:23-93.
17. Maggio JE (1988) Tachykinins. Annu Rev Neurosci 11:13-28.
18. Munson PJ and Rodbard D (1980) A versatile computerised approach for the characterisation of ligand binding systems. Anal Biochem 107:220-239.
19. Nakamaye KL and Eckstein F (1986) Inhibition of restriction endonuclease Ncil cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. Nucl Acids Res 14:9679-9698.
20. Otsuka M and Yoshioka K (1993) Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73:229-308.
21. 2 receptor. Biochem Biophys Res Commun 248:78-82.
22. Rotondaro L, Mazzanti L, Mele A and Rovera G (1997) High-level expression of cDNA for granulocyte colony-stimulating factor in Chinese hamster ovary cells: Effect of 3′-noncoding sequences. Mol Biotechnol 7:231-240.
23. Schwartz TW, Gether U, Schambye HT and Hjorth SA (1995) Molecular mechanisms of action of nonpeptide ligands for peptide receptors. Curr Pharmacol Des 1:325-342.
24. Taylor JW, Ott J and Eckstein F (1985) The rapid generation of oligonucleotide directed mutations at high frequency using phosphorothioate-modified DNA. Nucl Acids Res 13:8764-8785.
25. Urlaub G and Chasin LA (1980) Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc Natl Acad Sci USA 77:4216-4220.